Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1989 2
1990 1
1991 1
1992 1
1993 1
1994 1
1996 2
1997 5
1999 2
2000 1
2002 1
2003 2
2004 1
2005 1
2006 1
2007 1
2008 4
2009 2
2012 1
2013 2
2014 1
2017 5
2018 6
2019 3
2020 4
2021 4
2022 3
2024 0

Text availability

Article attribute

Article type

Publication date

Search Results

53 results

Results by year

Filters applied: . Clear all
Page 1
Teriparatide administration by the Omnipod pump: preliminary experience from two cases with refractory hypoparathyroidism.
Aouchiche K, Reynaud R, Amodru V, Brue T, Cuny T. Aouchiche K, et al. Endocrine. 2022 Apr;76(1):179-188. doi: 10.1007/s12020-021-02978-6. Epub 2022 Jan 4. Endocrine. 2022. PMID: 34984624 Review.
METHODS: We describe two cases of patients with refractory postsurgical hypoPTH, in whom subcutaneous infusion of recombinant PTH (teriparatide) through the Omnipod pump was initiated after failure of all other therapeutic options. ...As a last resort, teriparati
METHODS: We describe two cases of patients with refractory postsurgical hypoPTH, in whom subcutaneous infusion of recombinant PTH ( …
Non-chromatographic purification of Teriparatide with a pH-responsive CspB tag.
Nonaka T, Tsurui N, Mannen T, Kikuchi Y, Shiraki K. Nonaka T, et al. Protein Expr Purif. 2019 Mar;155:66-71. doi: 10.1016/j.pep.2018.11.008. Epub 2018 Nov 25. Protein Expr Purif. 2019. PMID: 30485791
The Teriparatide was constructed as CspB50TEV-Teriparatide, comprising 50 amino acid residues of CspB, the cleavage site of TEV protease, and Teriparatide. ...A TEV protease treatment was applied to cleave the Teriparatide from the CspB50TEV-Teripar
The Teriparatide was constructed as CspB50TEV-Teriparatide, comprising 50 amino acid residues of CspB, the cleavage site of TE …
Biological options to enhance periprosthetic bone mass.
Tsiridis E, Gamie Z, Conaghan PG, Giannoudis PV. Tsiridis E, et al. Injury. 2007 Jun;38(6):704-13. doi: 10.1016/j.injury.2007.02.051. Epub 2007 May 2. Injury. 2007. PMID: 17477926 Review.
Current evidence suggests that the short-term gains may not be sustained in the long term. Teriparatide and parathyroid hormone 1-84 have been licensed to treat postmenopausal osteoporosis and may also be investigated for the potential to enhance periprosthetic bone mass. …
Current evidence suggests that the short-term gains may not be sustained in the long term. Teriparatide and parathyroid hormone 1-84 …
Recombinant human PTH 1-34 (Forteo): an anabolic drug for osteoporosis.
Deal C, Gideon J. Deal C, et al. Cleve Clin J Med. 2003 Jul;70(7):585-6, 589-90, 592-4 passim. doi: 10.3949/ccjm.70.7.585. Cleve Clin J Med. 2003. PMID: 12882381 Free article. Review.
Forteo (teriparatide of rDNA origin), a genetically engineered fragment of parathyroid hormone, is the first of a new class of drugs to treat osteoporosis. ...
Forteo (teriparatide of rDNA origin), a genetically engineered fragment of parathyroid hormone, is the first of a new class of …
[Potential use of parathyroid hormone (PTH) in the treatments for oral diseases].
Tanaka S, Hata K, Yoneda T. Tanaka S, et al. Clin Calcium. 2012 Jan;22(1):75-82. Clin Calcium. 2012. PMID: 22201102 Review. Japanese.
Accumulated results show that intermittent PTH administration increases bone mass. Accordingly, recombinant N-terminal fragment of human PTH (1-34) , Teriparatide, is used for the treatments of osteoporosis worldwide. ...
Accumulated results show that intermittent PTH administration increases bone mass. Accordingly, recombinant N-terminal fragment of hu …
The use of intermittent human parathyroid hormone as a treatment for osteoporosis.
Deal C. Deal C. Curr Rheumatol Rep. 2004 Feb;6(1):49-58. doi: 10.1007/s11926-004-0083-3. Curr Rheumatol Rep. 2004. PMID: 14713402 Review.
PTH has been demonstrated to increase bone mass and reduce vertebral and nonvertebral fractures, and has been approved for use in the US and Europe. PTH is a genetically engineered 34 amino acid protein with the designation teriparatide (recombinant DNA origi …
PTH has been demonstrated to increase bone mass and reduce vertebral and nonvertebral fractures, and has been approved for use in the US and …
Parathyroid hormone regulates fates of murine osteoblast precursors in vivo.
Balani DH, Ono N, Kronenberg HM. Balani DH, et al. J Clin Invest. 2017 Sep 1;127(9):3327-3338. doi: 10.1172/JCI91699. Epub 2017 Jul 31. J Clin Invest. 2017. PMID: 28758904 Free PMC article.
Teriparatide, a recombinant form of parathyroid hormone (PTH), is the only approved treatment for osteoporosis that increases the rate of bone formation. Teriparatide increases osteoblast numbers by suppressing osteoblast apoptosis and activating bone-lining
Teriparatide, a recombinant form of parathyroid hormone (PTH), is the only approved treatment for osteoporosis that increases
Humoral hypercalcemia of malignancy.
Martin TJ. Martin TJ. Horm Res. 1989;32(1-3):84-8. doi: 10.1159/000181252. Horm Res. 1989. PMID: 2693318 Review.
A new pH-responsive peptide tag for protein purification.
Nonaka T, Tsurui N, Mannen T, Kikuchi Y, Shiraki K. Nonaka T, et al. Protein Expr Purif. 2018 Jun;146:91-96. doi: 10.1016/j.pep.2018.02.004. Epub 2018 Feb 10. Protein Expr Purif. 2018. PMID: 29432812
This peptide tag is a part of a cell surface protein B (CspB) derived from Corynebacterium glutamicum. Proinsulin that genetically fused with a peptide of N-terminal 6, 17, 50, or 250 amino acid residues of CspB showed that the reversible precipitation and redissolution de …
This peptide tag is a part of a cell surface protein B (CspB) derived from Corynebacterium glutamicum. Proinsulin that genetically fu …
Effect of Clp protease from Corynebacterium glutamicum on heterologous protein expression.
Liu X, Meng L, Wang X, Yang Y, Bai Z. Liu X, et al. Protein Expr Purif. 2022 Jan;189:105928. doi: 10.1016/j.pep.2021.105928. Epub 2021 Jul 2. Protein Expr Purif. 2022. PMID: 34217803
In this study, we used protease overexpression and deletion strategies to examine the effect of the Clp protease system in Corynebacterium glutamicum on the recombinant protein and to produce a highly efficient heterologous protein expression host. ...Furthermore, recom
In this study, we used protease overexpression and deletion strategies to examine the effect of the Clp protease system in Corynebacterium g …
53 results